Erech Finance Cahalacha Ltd (EFNC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Erech Finance Cahalacha Ltd (EFNC) has a cash flow conversion efficiency ratio of -0.213x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-925.00K ≈ $-2.48K USD) by net assets (ILA4.33 Million ≈ $11.62K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Erech Finance Cahalacha Ltd - Cash Flow Conversion Efficiency Trend (2014–2023)
This chart illustrates how Erech Finance Cahalacha Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Erech Finance Cahalacha Ltd (EFNC) total liabilities for a breakdown of total debt and financial obligations.
Erech Finance Cahalacha Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Erech Finance Cahalacha Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CFI-Compagnie Foncière Internationale
PA:CFI
|
0.135x |
|
Regent Pacific Properties Inc
V:RPP
|
0.061x |
|
Interactive Strength Inc. Common Stock
NASDAQ:TRNR
|
-0.352x |
|
KATORO GOLD PLC LS-01
F:622
|
N/A |
|
Diaceutics PLC
LSE:DXRX
|
0.021x |
|
ProAm Explorations Corp
V:PMX
|
0.370x |
|
Ramsdens Holdings PLC
LSE:RFX
|
0.016x |
|
GlucoTrack Inc
NASDAQ:GCTK
|
-1.392x |
Annual Cash Flow Conversion Efficiency for Erech Finance Cahalacha Ltd (2014–2023)
The table below shows the annual cash flow conversion efficiency of Erech Finance Cahalacha Ltd from 2014 to 2023. For the full company profile with market capitalisation and key ratios, see how much is Erech Finance Cahalacha Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | ILA4.33 Million ≈ $11.62K |
ILA-2.17 Million ≈ $-5.83K |
-0.502x | -201.92% |
| 2022-12-31 | ILA28.37 Million ≈ $76.05K |
ILA-4.72 Million ≈ $-12.64K |
-0.166x | +1.27% |
| 2021-12-31 | ILA53.16 Million ≈ $142.52K |
ILA-8.95 Million ≈ $-24.00K |
-0.168x | +25.43% |
| 2020-12-31 | ILA30.07 Million ≈ $80.62K |
ILA-6.79 Million ≈ $-18.21K |
-0.226x | -599.29% |
| 2019-12-31 | ILA11.76 Million ≈ $31.53K |
ILA532.00K ≈ $1.43K |
0.045x | +345.75% |
| 2018-12-31 | ILA17.93 Million ≈ $48.07K |
ILA-330.00K ≈ $-884.72 |
-0.018x | -100.02% |
| 2017-12-31 | ILA-63.00K ≈ $-168.90 |
ILA-7.68 Million ≈ $-20.59K |
121.921x | +1705.51% |
| 2016-12-31 | ILA-1.48 Million ≈ $-3.97K |
ILA-9.99 Million ≈ $-26.79K |
6.753x | +105.85% |
| 2015-12-31 | ILA178.00K ≈ $477.21 |
ILA-20.56 Million ≈ $-55.12K |
-115.511x | -1359.47% |
| 2014-12-31 | ILA5.09 Million ≈ $13.65K |
ILA-40.31 Million ≈ $-108.07K |
-7.915x | -- |
About Erech Finance Cahalacha Ltd
Erech Finance Cahalacha Ltd, together with its subsidiaries, provides loans and credit services to small and medium sized enterprises, associations, and private borrowers in Israel. It is also involved in the development of biomed-drugs in the areas of juvenile diabetes and cancer. The company was founded in 1998 and is based in Jerusalem, Israel.